Health

No OS Boost With Palbociclib and Endocrine Therapy in Premenopausal Breast Cancer

TribeNews
By TribeNews 4 Views Add a Comment
0 Min Read
No OS Boost With Palbociclib and Endocrine Therapy in Premenopausal Breast Cancer

MedPage Today) — No improvement in overall survival (OS) was observed with palbociclib (Verzenio) plus endocrine therapy versus capecitabine in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer, according…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app